As part of our technology expansion program, Sienna partners and forms relationships with research institutes, universities and existing companies.
Sienna is focussed on cancer related technology. We will develop the research and commercialise the the resultant products.
Sienna will leverage its expanding global sales and marketing channels to get products into the market to address unmet clinical needs.
Our goal is providing innovative tests that add value to clinicians and patients, wherever they may fit in the testing spectrum above.
To learn more about how Sienna's IVD test identifies hTERT as an adjunct to urine cytology, click here
To learn about the ribonucleoprotein Telomerase and the role it plays in cancer, click here
To learn more about our advanced capture program NETs and it's technology, click here
To learn about the advantages of our capture technology and how it assists cancer detection, click here